Table 2 Recommendations from MGTB, N = 40
Recommendation | Number of Patients | % | Number of Patients who followed MGTB recommendations | % |
|---|---|---|---|---|
Genetics consultation | 15 | 38 | 3 | 20 |
Clinical trial | 34 | 85 | 6 | 18 |
FDA-approved therapies | ||||
• On-label | 13 | 33 | 5 | 38 |
• Off-label | 0 | 0 | 0 | 0 |
Additional testing/biopsy | ||||
• Androgen receptor testing | 5 | 12 | 5 | 100 |
• Repeat HER2 testing | 2 | 5 | 2 | 100 |